Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
May 5, 2016
Malignancy associated SIADH: Characterization and clinical implications
H Goldvaser, B Rozen-Zvi, R Yerushalmi, et al.
Experimental Oncology
|
August 21, 2007
Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro
R Yerushalmi, J Nordenberg, E Beery, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2011
Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?
R Yerushalmi, S Tyldesley, R Woods, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2011
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome
R Yerushalmi, S Tyldesley, H Kennecke, et al.
Leukemia
|
August 11, 2007
Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan
A Shimoni, I Hardan, N Shem-Tov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2009
Decline in pulmonary function in patients with breast cancer receiving dose-dense chemotherapy: a prospective study
R Yerushalmi, M R Kramer, S Rizel, et al.
The British Journal of Radiology
|
December 1, 2011
CT in the clinical and prognostic evaluation of acute graft-vs-host disease of the gastrointestinal tract
A Shimoni, U Rimon, M Hertz, et al.
Leukemia
|
November 25, 2005
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity
A Shimoni, I Hardan, N Shem-Tov, et al.
Journal of Neuro-Oncology
|
June 13, 2013
Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis
S Yust-Katz, P Garciarena, D Liu, et al.
Leukemia
|
October 18, 2012
Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced
A Shimoni, N Shem-Tov, A Chetrit, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Acta Oncologica (Stockholm, Sweden)
|
May 5, 2016
Malignancy associated SIADH: Characterization and clinical implications
H Goldvaser, B Rozen-Zvi, R Yerushalmi, et al.
Experimental Oncology
|
August 21, 2007
Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro
R Yerushalmi, J Nordenberg, E Beery, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2011
Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?
R Yerushalmi, S Tyldesley, R Woods, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2011
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome
R Yerushalmi, S Tyldesley, H Kennecke, et al.
Leukemia
|
August 11, 2007
Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan
A Shimoni, I Hardan, N Shem-Tov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2009
Decline in pulmonary function in patients with breast cancer receiving dose-dense chemotherapy: a prospective study
R Yerushalmi, M R Kramer, S Rizel, et al.
The British Journal of Radiology
|
December 1, 2011
CT in the clinical and prognostic evaluation of acute graft-vs-host disease of the gastrointestinal tract
A Shimoni, U Rimon, M Hertz, et al.
Leukemia
|
November 25, 2005
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity
A Shimoni, I Hardan, N Shem-Tov, et al.
Journal of Neuro-Oncology
|
June 13, 2013
Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis
S Yust-Katz, P Garciarena, D Liu, et al.
Leukemia
|
October 18, 2012
Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced
A Shimoni, N Shem-Tov, A Chetrit, et al.
Page
of 4